|
APOOL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.00639998743691E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.35550032204424E-10 |
| Normal-vs-Stage2 |
2.635600E-02 |
| Normal-vs-Stage3 |
5.380200E-04 |
| Normal-vs-Stage4 |
3.54959999999682E-05 |
| Stage1-vs-Stage2 |
2.345600E-01 |
| Stage1-vs-Stage3 |
3.032200E-01 |
| Stage1-vs-Stage4 |
4.418600E-01 |
| Stage2-vs-Stage3 |
6.247600E-01 |
| Stage2-vs-Stage4 |
1.956240E-01 |
| Stage3-vs-Stage4 |
2.802600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.61079996405545E-09 |
| Normal-vs-AfricanAmerican |
1.40310000285027E-08 |
| Normal-vs-Asian |
9.589000E-04 |
| Caucasian-vs-AfricanAmerican |
7.360000E-01 |
| Caucasian-vs-Asian |
5.650800E-01 |
| AfricanAmerican-vs-Asian |
6.112600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90714111170109E-12 |
| Normal-vs-Female |
1.180610E-03 |
| Male-vs-Female |
2.175200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.94350000000321E-05 |
| Normal-vs-Extreme_Weight |
1.63924429585904E-12 |
| Normal-vs-Obese |
3.16369999997512E-06 |
| Normal-vs-Extreme_Obese |
1.096440E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.124200E-01 |
| Normal_Weight-vs-Obese |
7.628600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.800400E-01 |
| Extreme_Weight-vs-Obese |
1.441790E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.860790E-01 |
| Obese-vs-Extreme_Obese |
8.694800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.387900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.86589999509701E-08 |
| Normal-vs-Age(61-80Yrs) |
3.94040000628593E-09 |
| Normal-vs-Age(81-100Yrs) |
2.1483999999905E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.366800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.451600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.057600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.820600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.714000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.569200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64324109874769E-12 |
| Normal-VS-Type2 PRCC |
4.045300E-04 |
| Normal-VS-KIRP CIMP |
1.691820E-02 |
| Normal-VS-Unclassified PRCC |
4.228300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.718600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.192500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.237000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.299200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.479000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.921800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.37269999994838E-06 |
| Normal-vs-N1 |
1.74939999999513E-05 |
| Normal-vs-N2 |
1.853800E-02 |
| N0-vs-N1 |
9.736400E-01 |
| N0-vs-N2 |
9.508000E-01 |
| N1-vs-N2 |
9.187400E-01 |
|
|
